Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
Date:6/2/2008

Phase 2 Results of Perifosine in the Treatment of Patients with

Relapsed/Refractory Waldenstrom's Macroglobulinemia to be presented

Tomorrow, Tuesday, June 3rd at 12:00pm in Room E450a

NEW YORK, June 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that abstracts related to KRX-0401 (Perifosine) have been selected for both poster presentation and publication during the American Society of Clinical Oncology Meeting currently taking place in Chicago, Illinois (May 31 - June 3, 2008).

Copies of these abstracts, which highlight the observed clinical and preclinical activity of KRX-0401 as a single agent and in combination with novel agents are currently available and can be viewed on-line through the ASCO website: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts

The following abstract will be available for viewing during the poster session taking place tomorrow, Tuesday, June 3, 2008, from 8:00am-12:00pm:

Abstract 8546: A Phase 2 trial of the novel oral Akt inhibitor perifosine in relapsed and/or refractory Waldenstrom macroglobulinemia

Investigators: Irene M. Ghobrial, X. Leleu, N. Rubin, R. Leduc, S. Chuma, M. Nelson, P. G. Richardson, S. P. Treon, K. C. Anderson

Following the poster session, lead investigator, Dr. Irene Ghobrial, will be presenting the abstract during the Lymphoma and Plasma Cell Disorders Poster Discussion Forum, scheduled to take place at 12:00pm in Room E450a.

Additionally, the following abstracts have been accepted for publication only:

Abstract 16024: Phase 1 multicenter trial of perifosine in
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
2. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
3. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
4. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
5. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
8. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... December 17, 2014 Revenue and earnings ... on research and development In the past 2013/14 ... by two percent to EUR 4.287 billion (last year: EUR ... 14 percent to EUR 360 million. "Overall, 2013/14 was a ... Michael Kaschke , President and CEO of Carl Zeiss AG. ...
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... SAN DIEGO, March 30, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ... City.   The live presentation takes place ... / 10:20 a.m. Pacific Time.  The presentation will be webcast ...
... AAIPharma Services Corp., a leading provider of ... its compendial raw materials testing group to a ... Wilmington, N.C., headquarters facility. The move follows a ... analytical testing business. (Logo:   http://photos.prnewswire.com/prnh/20110330/CG74146LOGO ...
Cached Medicine Technology:AAIPharma Services Announces Compendial Testing Facility Expansion 2
(Date:12/20/2014)... December 20, 2014 Developers of ... of a new plugin for Final Cut Pro X ... “TranSlice Volume 5 allows users to create hand drawn ... Said Christina Austin, CEO of Pixel Film Studios. “TranSlice ... professionalism while maintaining an easy to use interface.” , ...
(Date:12/19/2014)... Balfleet.com , a leading dress company of wedding ... All the old and new customers can get a ... well-known for its high quality trendy women’s dresses, like ... more. Its formal dresses are quality made and come ... an elegant look when paired with any accessory. ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 ... dedicated to developing educational events, tools and resources ... Rouxbe Cooking School , the world’s leading online ... prescription every human being needs: Culinary Rx. As ... cooking course, Culinary Rx, scheduled for debut spring ...
(Date:12/19/2014)... 2014 An evening dress is perfect for ... closet. Discount-Dress.com, a distinguished dresses retailer, has unveiled its new ... in this great shopping platform. Customers can view ... hard work, Discount-Dress.com has been accepted and praised by customers ... easier shopping stage for clients. In order to expand its ...
(Date:12/19/2014)... News) -- All children should have their eyesight checked ... year, eye experts say. The new vision-screening guidelines ... the U.S. National Center for Children,s Vision Health. ... require screening for eye problems, particularly vision issues ... eye") and strabismus (a disorder of eye alignment). ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Preschoolers Need Eye Screening, Experts Say 2
... ... offering vein treatment and cosmetic plastic surgery in Tampa Bay, Florida ... technology in the treatment of skin affected by sun damage, wrinkling, and ... Cosmetic Center of Tampa Bay utilizes CO2 Fractional laser systems, ActiveFX™, DeepFX, ...
... spend less time on academics with video-game systems at home ... that young boys who own a video game system don,t ... time spent playing video games is supplanting time spent on ... psychology at Denison University in Ohio, said that "we can ...
... ... biofeedback should consider visiting the new Absolute Health office. The new office is located at ... ... who are searching for allergy relief , chiropractic and biofeedback ...
... March 17 Stonebranch, the industry leader in ... and Job Scheduling technology , announced today the publication ... What the HITECH Act Means for U.S. Healthcare Organizations, Communications ... regulations and how healthcare organizations (HCOs), related covered entities (CE) ...
... ... ... -- The Physician’s Coalition for Injectable Safety warns against “Teen Toxing” or the administration ... cosmetic reasons. According to an article published in the UK Daily Mail, a 15-year-old ...
... ... , ... 17, 2010 -- Tahitian Noni International (TNI) announced the introduction of two new ... bioactive beverages are delicious and loaded with iridoids and other bioactive compounds that ...
Cached Medicine News:Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 2Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 3Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 4Health News:'Gaming' Sends Boys' Test Scores Sliding 2Health News:'Gaming' Sends Boys' Test Scores Sliding 3Health News:Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona 2Health News:Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona 3Health News:Stonebranch Publishes Healthcare IT White Paper 2Health News:Stonebranch Publishes Healthcare IT White Paper 3Health News:Stonebranch Publishes Healthcare IT White Paper 4Health News:"Teen Toxing”: Dangerous Trend Developing in UK Schools 2Health News:"Teen Toxing”: Dangerous Trend Developing in UK Schools 3Health News:"Teen Toxing”: Dangerous Trend Developing in UK Schools 4Health News:Tahitian Noni Family Released in Grape and Mango Passionfruit 2
... including the Ceralas D and SmilePro 980 ... medical, dental, and veterinary environments.,With unsurpassed, optimal ... nm laser series allow controlled tissue ablation ... surgical procedures. Unlike other medical lasers, biolitecs ...
... The lightweight and portable AccuPach V Pachymeter ... touch screen and a synthesized voice that announces ... probe, and the unit has an optional printer ... can enter measured intraocular pressure into the unit ...
... GonoGen™ II is a monoclonal antibody ... confirmatory identification of Neisseria gonorrhoeae. The ... to run with no heating or ... isolated, viable or fresh cultures. GonoGen&trade ...
... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
Medicine Products: